PMCPA Guidance Documents: Package Deals & Transfer of Value
Friday 27th November 2026 13:00 - 14:00 (GMT)
A practical guide to package deals, governance and transfer of value disclosure
Masterclass Details:
In January 2026 the Prescription Medicines Code of Practice Authority (PMCPA) published new guidance on package deals covering classification, governance, written agreements, communication and disclosure of transfers of value. Do you know what you need to do to stay compliant?
In this 60-minute masterclass, compliance expert Sue Jameson will set out the parameters and get into problem-solving mode to give you ideas, decisions to be made and a way of moving forward.
An analysis conducted in 2025 with input from pharma companies, service providers and healthcare organisations showed that there was significant variation, particularly in relation to transfer of value.
Industry stakeholders now have until June 2027 to review their package deals and make some key decisions, especially on how to disclose transfer of value for package deals. Discover how to navigate evolving PMCPA expectations, reduce compliance risk and develop a clear path forward in this essential event.
Join live to ask your questions, explore the guidance and ensure your company’s compliance into 2027.
Key Learning Objectives:
• Understand the latest PMCPA guidance on package deals, with particular reference to transfer of value
• Explore the different disclosure approaches taken by pharma companies
• Identify the key compliance risks and practical challenges associated with package deals
• Explore practical solutions and decision-making frameworks to support consistent and transparent disclosure practices
• Develop a compliant and workable approach to package deals that aligns with evolving PMCPA expectations and industry best practice
LSAA reserves the right to restrict access to this webinar to LSAA members
-
Date and time
27th Nov 2026 13:00 – 14:00 (GMT)
